Accuray, Inc. (NASDAQ:ARAY)

CAPS Rating: 4 out of 5

The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.

Recs

0
Player Avatar MarketHustler (< 20) Submitted: 8/22/2011 8:45:00 PM : Outperform Start Price: $4.53 ARAY Score: +19.40

Buying at a discount and there is really nothing to show why they are so undervalued except for S&P downgrade scare. Waiting for some consolidation

Featured Broker Partners


Advertisement